Arthur G James Cancer Hospital and Research Institute

Arthur G James Cancer Hospital and Research Institute was paid $140.71M by Medicaid between Jan 2018 and Dec 2024, across 390 billing codes. Its largest line is J9271, Injection, pembrolizumab, 1 mg — 19% of everything it billed.

33Billing provider infoARTHUR G JAMES CANCER HOSPITAL AND RESEARCH INSTITUTE
COLUMBUS, OH 43210

33aNPI1124127683assigned 09/21/2006

33bProvider typeSpecial Hospital

28Total paid$140.71M

24GClaims794,957

24DCodes billed390

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Special Hospital providers in Ohio

Rank by total paid#1 of 5

Median peer was paid$7.30M

This provider vs. median19×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	35,126	$1.34M
2019	29,021	$1.61M
2020	16,383	$1.12M
2021	17,769	$1.29M
2022	31,127	$1.69M
2023	373,889	$76.46M
2024incomplete	291,642	$57.20M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J9271	Injection, pembrolizumab, 1 mg	19%	1,856	1,231	$27.26M
77386		11%	9,790	962	$15.54M
J9299	Injection, nivolumab, 1 mg	6.4%	731	388	$9.07M
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	4.0%	1,194	777	$5.58M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	3.2%	17,397	9,049	$4.53M
J9358	Injection, fam-trastuzumab deruxtecan-nxki, 1 mg	2.8%	741	264	$4.00M
J9306	Injection, pertuzumab, 1 mg	2.7%	448	284	$3.74M
J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	2.6%	483	254	$3.65M
77301		2.2%	748	645	$3.16M
78815	Positron emission tomography (PET) for limited area imaging	2.0%	1,964	1,718	$2.82M
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	1.7%	841	340	$2.41M
71260	Computed tomography, thorax, diagnostic; with contrast material	1.4%	4,962	4,121	$2.04M

378 more codes

74177	Computed tomography, abdomen and pelvis; with contrast material	1.4%	4,079	$1.96M
80053	Comprehensive metabolic panel	1.4%	33,569	$1.92M
77334		1.3%	1,486	$1.83M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	1.3%	37,133	$1.78M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.2%	60,925	$1.75M
77300		1.2%	1,221	$1.74M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.2%	2,816	$1.66M
G0378	Hospital observation service, per hour	1.1%	1,850	$1.57M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	26,520	$1.40M
77336		<1%	3,097	$1.38M
J9202	Goserelin acetate implant, per 3.6 mg	<1%	1,185	$1.25M
77412		<1%	2,101	$1.21M
96417		<1%	4,637	$1.18M
96415		<1%	3,842	$1.05M
76642		<1%	3,358	$1.03M
77373		<1%	556	$924K
J0185	Injection, aprepitant, 1 mg	<1%	1,794	$920K
J9035	Injection, bevacizumab, 10 mg	<1%	511	$799K
J2997	Injection, alteplase recombinant, 1 mg	<1%	702	$799K
77338		<1%	714	$798K
J1454	Injection, fosnetupitant 235 mg and palonosetron 0.25 mg	<1%	927	$797K
77295		<1%	335	$689K
80051		<1%	15,692	$661K
96416		<1%	1,616	$626K
36591		<1%	8,999	$610K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	864	$600K
36430		<1%	2,104	$564K
J0897	Injection, denosumab, 1 mg	<1%	231	$546K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	1,826	$538K
P9037	Platelets, pheresis, leukocytes reduced, irradiated, each unit	<1%	672	$524K
J9173	Injection, durvalumab, 10 mg	<1%	47	$489K
88185		<1%	10,654	$482K
38222		<1%	432	$475K
J9022	Injection, atezolizumab, 10 mg	<1%	39	$462K
99213	Doctor's office visit, returning patient (routine)	<1%	6,934	$430K
77385		<1%	257	$424K
96402		<1%	3,086	$416K
19083		<1%	262	$414K
76536		<1%	1,503	$407K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	2,648	$401K
77290		<1%	528	$400K
36415	Collection of venous blood by venipuncture	<1%	28,551	$400K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	623	$376K
74183		<1%	578	$374K
96375	Therapeutic injection; each additional sequential IV push	<1%	10,118	$340K
78306		<1%	596	$337K
77066	Tomosynthesis, mammo	<1%	1,901	$333K
70491		<1%	987	$325K
J3490	Unclassified drugs	<1%	5,877	$317K
77049		<1%	360	$303K
88307		<1%	2,343	$285K
31575		<1%	1,404	$273K
J0791	Injection, crizanlizumab-tmca, 5 mg	<1%	26	$255K
80076		<1%	7,356	$254K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	6,275	$254K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	3,641	$252K
88341		<1%	6,326	$244K
71250		<1%	1,108	$242K
00320		<1%	358	$239K
72197		<1%	468	$234K
Q9968	Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg	<1%	101	$231K
82565		<1%	21,001	$231K
88342		<1%	2,793	$225K
31579		<1%	579	$211K
86923		<1%	2,313	$208K
84520		<1%	15,912	$206K
36593		<1%	504	$202K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	837	$199K
83615		<1%	14,209	$193K
J9070	Cyclophosphamide, 100 mg	<1%	1,116	$190K
86900		<1%	4,333	$189K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	2,367	$188K
36592		<1%	3,061	$186K
76830	Ultrasound, transvaginal	<1%	827	$183K
74178		<1%	346	$178K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	4,051	$173K
96411		<1%	1,164	$170K
83735		<1%	9,848	$167K
82784		<1%	9,196	$165K
96409		<1%	1,033	$159K
88184		<1%	1,096	$157K
J1170	Injection, hydromorphone, up to 4 mg	<1%	3,568	$150K
96401		<1%	1,143	$150K
52000		<1%	252	$150K
81450		<1%	271	$146K
84443	Thyroid stimulating hormone (TSH)	<1%	9,349	$139K
77065	Tomosynthesis, mammo	<1%	1,051	$138K
84439		<1%	7,712	$134K
86850		<1%	4,207	$130K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	7,849	$124K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	766	$123K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	2,812	$121K
36561		<1%	86	$121K
85610		<1%	9,246	$112K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	199	$110K
J9395	Injection, fulvestrant, 25 mg	<1%	400	$110K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	959	$108K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	3,266	$108K
86905		<1%	851	$107K
72158		<1%	184	$105K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	1,440	$105K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	869	$104K
76641		<1%	181	$102K
88237		<1%	963	$101K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	1,817	$101K
J1750	Injection, iron dextran, 50 mg	<1%	264	$100K
J9190	Injection, fluorouracil, 500 mg	<1%	1,628	$100K
86334		<1%	2,679	$98K
82378		<1%	1,862	$98K
76942		<1%	568	$95K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	13,586	$95K
87799		<1%	1,978	$91K
88360		<1%	1,026	$89K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	3,124	$85K
82728		<1%	4,835	$85K
96361	Intravenous infusion, hydration; each additional hour	<1%	1,867	$84K
J9267	Injection, paclitaxel, 1 mg	<1%	2,085	$84K
77063	Screening digital breast tomosynthesis, bilateral	<1%	3,827	$81K
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	85	$81K
97535	Self-care/home management training, each 15 minutes	<1%	1,732	$80K
J9075	Injection, cyclophosphamide, not otherwise specified, 5 mg	<1%	252	$80K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	266	$78K
00400		<1%	125	$76K
71046	Radiologic examination, chest; 2 views	<1%	1,047	$76K
84153		<1%	2,077	$76K
87497		<1%	1,154	$75K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	944	$74K
72157		<1%	128	$74K
81206		<1%	313	$74K
82310		<1%	5,280	$73K
84165		<1%	2,902	$72K
80377		<1%	356	$71K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	5,092	$69K
85027		<1%	8,432	$68K
97162		<1%	826	$64K
96377		<1%	1,224	$64K
J9045	Injection, carboplatin, 50 mg	<1%	1,974	$63K
A9800	Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie	<1%	33	$60K
88313		<1%	1,498	$60K
96367		<1%	2,105	$59K
84100		<1%	5,216	$59K
76770		<1%	393	$58K
86901		<1%	4,334	$56K
72156		<1%	93	$55K
84466		<1%	2,962	$53K
92612		<1%	468	$53K
A4648	Tissue marker, implantable, any type, each	<1%	705	$53K
J9171	Injection, docetaxel, 1 mg	<1%	518	$50K
88264		<1%	419	$50K
88275		<1%	1,528	$50K
96376		<1%	2,224	$48K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	1,466	$47K
J9206	Injection, irinotecan, 20 mg	<1%	867	$47K
A9587	Gallium ga-68, dotatate, diagnostic, 0.1 millicurie	<1%	15	$46K
84432		<1%	803	$45K
86920		<1%	580	$43K
88271		<1%	1,753	$42K
J2704	Injection, propofol, 10 mg	<1%	3,304	$42K
84146		<1%	996	$42K
81025		<1%	2,119	$41K
85045		<1%	5,001	$41K
84155		<1%	2,919	$41K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,679	$41K
99214	Doctor's office visit, returning patient (more involved)	<1%	514	$40K
82248		<1%	5,484	$40K
78816		<1%	26	$39K
76882		<1%	266	$39K
97161		<1%	564	$39K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,205	$38K
77280		<1%	88	$38K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	475	$37K
71045	Radiologic examination, chest; single view	<1%	728	$37K
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	<1%	352	$36K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	1,780	$35K
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	1,189	$35K
86301		<1%	807	$35K
C1769	Guide wire	<1%	487	$35K
80048	Basic metabolic panel (calcium, ionized)	<1%	1,212	$34K
83520		<1%	2,521	$34K
71271		<1%	232	$34K
J3489	Injection, zoledronic acid, 1 mg	<1%	552	$34K
82533		<1%	949	$33K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	6,131	$33K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	1,142	$33K
85730		<1%	2,391	$32K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	3,912	$32K
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	742	$32K
70543		<1%	63	$32K
C1726	Catheter, balloon dilatation, non-vascular	<1%	118	$32K
86304		<1%	439	$31K
77387		<1%	212	$30K
92597		<1%	414	$29K
84550		<1%	3,531	$29K
77080		<1%	333	$28K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	3,205	$28K
77011		<1%	82	$28K
C1830	Powered bone marrow biopsy needle	<1%	241	$27K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,765	$27K
84403		<1%	878	$27K
82947		<1%	4,431	$27K
85007		<1%	5,689	$27K
82040		<1%	3,271	$26K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	593	$26K
G0296	Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)	<1%	369	$24K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	494	$24K
84703		<1%	2,000	$24K
31237		<1%	18	$23K
83540		<1%	2,971	$23K
76377		<1%	215	$23K
82670		<1%	421	$22K
81001		<1%	2,987	$22K
C1788	Port, indwelling (implantable)	<1%	86	$22K
83001		<1%	571	$21K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	917	$21K
80197		<1%	907	$19K
76937		<1%	298	$19K
70450	Computed tomography, head or brain; without contrast material	<1%	86	$19K
84075		<1%	2,986	$19K
J9305	Injection, pemetrexed, not otherwise specified, 10 mg	<1%	320	$18K
84450		<1%	3,050	$18K
84460		<1%	2,949	$18K
50200		<1%	27	$18K
82247		<1%	3,038	$18K
99215	Doctor's office visit, returning patient (complex)	<1%	181	$18K
A9573	Injection, gadopiclenol, 1 ml	<1%	1,252	$17K
88112		<1%	401	$17K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	1,005	$17K
83021		<1%	368	$17K
77001		<1%	201	$16K
86800		<1%	801	$16K
J1453	Injection, fosaprepitant, 1 mg	<1%	379	$16K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	2,770	$15K
83970		<1%	548	$15K
J7999	Compounded drug, not otherwise classified	<1%	749	$15K
83521		<1%	3,741	$14K
83010		<1%	902	$14K
88374		<1%	109	$14K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	846	$14K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	3,651	$14K
86360		<1%	353	$13K
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	595	$13K
88309		<1%	84	$13K
77293		<1%	54	$13K
71275	Computed tomographic angiography, chest, with contrast material	<1%	42	$13K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	1,384	$13K
82024		<1%	184	$13K
82105		<1%	830	$13K
77470		<1%	17	$13K
86870		<1%	89	$12K
86880		<1%	502	$12K
C1729	Catheter, drainage	<1%	218	$12K
83880		<1%	388	$12K
88365		<1%	130	$11K
87088		<1%	1,108	$11K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	574	$11K
82607		<1%	1,069	$11K
87077		<1%	1,073	$11K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	107	$11K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,118	$10K
82570		<1%	1,404	$10K
88311		<1%	513	$9K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	124	$9K
88173		<1%	156	$9K
85652		<1%	1,245	$9K
86706		<1%	528	$9K
86704		<1%	633	$9K
J1644	Injection, heparin sodium, per 1000 units	<1%	875	$8K
74160		<1%	33	$8K
G0008	Administration of influenza virus vaccine	<1%	321	$8K
00731		<1%	71	$8K
80061	Lipid panel	<1%	833	$8K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	101	$8K
83002		<1%	220	$8K
91322		<1%	93	$8K
97760		<1%	156	$7K
86803		<1%	658	$7K
84305		<1%	119	$7K
84484		<1%	701	$7K
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	757	$7K
00940		<1%	20	$7K
92567		<1%	188	$7K
86140		<1%	1,042	$6K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	217	$6K
J0690	Injection, cefazolin sodium, 500 mg	<1%	344	$6K
84156		<1%	951	$6K
88331		<1%	71	$6K
87040		<1%	189	$6K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	172	$6K
87070		<1%	287	$6K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	4,899	$5K
83605		<1%	330	$5K
86038		<1%	248	$5K
87340		<1%	560	$5K
84481		<1%	430	$5K
93702		<1%	49	$5K
82746		<1%	572	$5K
83690		<1%	669	$5K
74230		<1%	44	$5K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	156	$5K
92526		<1%	89	$5K
97166		<1%	73	$4K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	19	$4K
99195		<1%	50	$4K
82550		<1%	516	$4K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	199	$4K
92611		<1%	54	$4K
J2060	Injection, lorazepam, 2 mg	<1%	459	$4K
82043		<1%	394	$4K
86316		<1%	163	$4K
99203	Doctor's office visit, new patient (routine)	<1%	57	$3K
74220		<1%	37	$3K
84702		<1%	227	$3K
J8540	Dexamethasone, oral, 0.25 mg	<1%	5,100	$3K
00300		<1%	15	$3K
82232		<1%	69	$3K
86300		<1%	61	$3K
87536		<1%	33	$2K
51798		<1%	70	$2K
81002		<1%	258	$2K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	306	$2K
81003		<1%	319	$2K
85018		<1%	539	$2K
J1171	Injection, hydromorphone, 0.1 mg	<1%	209	$2K
85384		<1%	117	$2K
90686		<1%	121	$2K
90480		<1%	86	$2K
85240		<1%	36	$2K
87205		<1%	247	$2K
0004A		<1%	54	$2K
96368		<1%	89	$2K
87186		<1%	217	$2K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	121	$2K
82330		<1%	69	$1K
J1630	Injection, haloperidol, up to 5 mg	<1%	383	$1K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	1,202	$1K
73502		<1%	12	$1K
74018		<1%	36	$1K
85014		<1%	319	$1K
90662		<1%	73	$1K
J0736	Injection, clindamycin phosphate, 300 mg	<1%	23	$1K
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	218	$1K
86644		<1%	32	$997.92
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	171	$923.62
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	20	$866.45
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	22	$824.16
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	17	$823.19
J9181	Injection, etoposide, 10 mg	<1%	35	$814.47
82150		<1%	153	$813.53
85397		<1%	14	$751.35
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	76	$735.81
97763		<1%	15	$717.91
84132		<1%	114	$685.14
86431		<1%	52	$594.71
85049		<1%	79	$575.34
86480		<1%	13	$573.42
87449		<1%	24	$536.63
0002A		<1%	16	$501.18
J3260	Injection, tobramycin sulfate, up to 80 mg	<1%	28	$499.43
G0009	Administration of pneumococcal vaccine	<1%	15	$465.92
83935		<1%	31	$382.43
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	<1%	60	$336.46
90656		<1%	28	$287.70
82977		<1%	27	$280.51
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	<1%	55	$270.65
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	45	$255.90
85613		<1%	16	$252.18
0753T		<1%	745	$244.30
84480		<1%	15	$239.50
J3480	Injection, potassium chloride, per 2 meq	<1%	20	$239.10
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	774	$220.19
85670		<1%	16	$138.46
91300		<1%	107	$116.55
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	142	$113.99
0754T		<1%	285	$109.48
Q0164	Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	269	$62.76
J9370	Vincristine sulfate, 1 mg	<1%	17	$28.11
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	63	$6.91
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	614	$0.03

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGOERLITZ, RYAN (CHIEF FINANCIAL OFFICER)